5,656 CVS Health Corporation $CVS Shares Purchased by Lido Advisors LLC

Lido Advisors LLC lifted its position in CVS Health Corporation (NYSE:CVS) by 10.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 59,355 shares of the pharmacy operator’s stock after buying an additional 5,656 shares during the quarter. Lido Advisors LLC’s holdings in CVS Health were worth $5,086,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Kilter Group LLC bought a new stake in CVS Health during the 2nd quarter worth approximately $27,000. Beaird Harris Wealth Management LLC lifted its stake in CVS Health by 201.0% in the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 195 shares in the last quarter. J.Safra Asset Management Corp bought a new position in CVS Health in the 2nd quarter valued at $30,000. Timbuktu Capital Management LLC bought a new position in CVS Health in the 2nd quarter valued at $31,000. Finally, Dunhill Financial LLC purchased a new position in shares of CVS Health during the 2nd quarter valued at $32,000. 80.66% of the stock is currently owned by institutional investors.

CVS Health Price Performance

CVS stock opened at $89.69 on Friday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.66. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The stock has a market cap of $114.76 billion, a PE ratio of 10.44, a P/E/G ratio of 0.78 and a beta of 0.58. The firm has a 50 day simple moving average of $89.81 and a two-hundred day simple moving average of $89.00.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share for the quarter, beating the consensus estimate of $1.65 by $0.44. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The firm had revenue of $108.40 billion for the quarter, compared to analysts’ expectations of $104.72 billion. During the same quarter last year, the company posted $1.60 EPS. The business’s quarterly revenue was up 5.4% on a year-over-year basis. On average, analysts predict that CVS Health Corporation will post 8.26 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Investors of record on Thursday, October 22nd were paid a $0.6650 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend was Thursday, October 22nd. CVS Health’s dividend payout ratio is currently 30.97%.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on CVS. BMO Capital Markets set a $112.00 price target on shares of CVS Health in a report on Wednesday, September 9th. Wells Fargo & Company dropped their price objective on CVS Health from $123.00 to $112.00 and set an “overweight” rating for the company in a research note on Thursday. Barclays reduced their target price on CVS Health from $108.00 to $107.00 and set an “overweight” rating for the company in a research report on Thursday, November 5th. Sanford C. Bernstein restated an “outperform” rating and issued a $112.00 target price on shares of CVS Health in a research note on Wednesday, September 9th. Finally, Argus raised their price target on CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a report on Wednesday, August 19th. Twenty-three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and an average target price of $107.79.

CVS Health News Roundup

Here’s some of the latest news about CVS:

• Positive Sentiment: CVS reported quarterly adjusted earnings of $2.09 per share, beating the $1.65 consensus estimate, while revenue rose 5.4% year over year to $108.4 billion. The earnings beat and growth support the case for improved operating performance. Article: CVS Beat Earnings by 27% and Split in Two
• Positive Sentiment: CVS’s planned 2028 split could sharpen strategic focus and improve capital allocation, potentially unlocking value in its businesses. Wells Fargo kept an “overweight” rating and sees its $112 price target as implying upside, despite lowering the target from $123. Article: Can CVS Health’s 2028 Split Unlock Value Despite Execution Risks?
• Neutral Sentiment: Wells Fargo’s price-target cut signals more cautious valuation assumptions, though its continued overweight rating indicates the analyst remains positive on CVS. Article: Wells Fargo rating and price target

Insider Buying and Selling

In other news, EVP Prem Shah purchased 23,855 shares of the stock in a transaction on Friday, November 6th. The shares were acquired at an average price of $83.89 per share, for a total transaction of $2,001,195.95. Following the completion of the transaction, the executive vice president directly owned 88,516 shares of the company’s stock, valued at approximately $7,425,607.24. This trade represents a 36.89% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. 0.85% of the stock is currently owned by corporate insiders.

CVS Health Profile

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.